BiotechTube
Home/Tessara Therapeutics/Phil Smith
PS

Phil Smith

Director

Tessara Therapeutics

Therapeutic Areas

NeurologyAlzheimer's diseaseCNS disorders

Tessara Therapeutics Pipeline

DrugIndicationPhase
ArtiBrain™Healthy human brain modelPreclinical
ADBrain™Alzheimer's disease modelPreclinical

Leadership Team at Tessara Therapeutics

CP
Christos Papadimitriou
CEO & Managing Director
PP
Prof. Paul Adlard
Chief Scientific Officer
PG
Peter Girling
Chief Operating Officer
TW
Tracy Weimar
Company Secretary, CFO
GC
Greg Collier
Chairman
CB
Christopher Boyer
Director
View full Tessara Therapeutics profile